Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
chamomile tincture
- Development stage
- Phase 1
- Administration
- Oral, Topical
01
Overview
Chamomile tincture is a liquid herbal extract made from chamomile flowers (typically Matricaria recutita or Chamaemelum nobile). It contains active compounds including sesquiterpenes, flavonoids, and essential oils. The tincture is used medicinally for anxiety, digestive disorders, inflammation, pain relief, and sleep issues. It's typically prepared in a 1:5 concentration with 45% alcohol.
- Other names
- chamomilla tincture
02
Targets
BZD site (GABA-A receptor benzodiazepine site)GABA-B (Gamma-aminobutyric acid receptor type B)
Beyond the preview
Go deeper on chamomile tincture.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on chamomile tincture.